NSE filing, NSE: CHANDAN. Summary written from the filing by ALFA Finder's alert engine.
Chandan Healthcare Ltd: key numbers
- Share price
- ₹235.00
- Market cap
- ₹604.0 Cr
- Revenue (annual)
- ₹276.4 Cr
- Net profit (annual)
- ₹28.55 Cr
- P/E (TTM)
- 21.1×Sector 52.3×
- Promoter holding
- 47.20%-2.41% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandan Healthcare Ltd
All →Chandan Healthcare Annual General Meeting
Chandan Healthcare calls an EGM on 20 November 2026 to approve related party transactions, including director guarantees. E-voting runs 17 to 19 November 2026.
Chandan Healthcare Results Update
Chandan Healthcare's Q2 FY2027 revenue from diagnostics grew 46.66% YoY to Rs. 56.38 Crore, while its franchise network expanded to 685 locations.
- franchise expansion
- 410.0 franchises
Chandan Healthcare Debt & Borrowing: ₹5.22 Cr
Chandan Healthcare Limited secured a ₹5.22 Crore medical equipment loan from ICICI Bank for purchasing a 128-slice CT scanner.
- Value
- ₹5.22 Cr
- Execution
- 60 months
Chandan Healthcare Management Change
Mr. Vinod Jain has resigned from his position as Independent Director of Chandan Healthcare Limited, effective October 5, 2026, due to other professional commitments.
Chandan Healthcare Annual General Meeting
Chandan Healthcare Limited held its 23rd Annual General Meeting on September 30, 2026. The meeting covered routine business, including financial adoption and board appointments.
Chandan Healthcare Capital Structure Change
Chandan Healthcare allotted 6,50,000 equity shares upon conversion of warrants for ₹15.21 Crore consideration.
- Value
- ₹15.21 Cr
Other other announcement announcements
All →Asian Energy Services Other Announcement
Asian Energy Services filed the Q2 FY2026-27 monitoring agency report on preferential convertible warrant proceeds. The report states no deviation from the offer objects.
Rexpro Enterprises Other Announcement
Rexpro Enterprises filed the Acuité monitoring agency report for H1 FY2026-27 on IPO proceeds. The report flags delayed utilisation and an unused inorganic-growth object past its March 2026 timeline.
Nakoda Group Of Industries Other Announcement
Nakoda Group filed its quarterly Reg 32 statement on fund use from the preferential issue of 87,00,000 convertible warrants. It reports no deviation or variation, with ₹6.09 Crore received as the 25% upfront payment.
Arman Financial Services Other Announcement
Arman Financial Services disclosed its quarterly shareholding pattern as of 30 September 2026. Promoter and public holdings are reported in the standard Regulation 31 format.
Muthoot Microfin Other Announcement
Muthoot Microfin filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold about 55.47%, with no transaction reported.
Hittco Tools Other Announcement
Hittco Tools filed its quarterly shareholding pattern for the quarter ended 30 September 2026. The filing discloses promoter, public and category-wise holdings.